The antiemetic efficacy of granisetron plus dexamethasone, haloperidol and loracepam in breast cancer patients treated with high-dose chemotherapy with peripheral blood stem-cell support

Supportive Care in Cancer

Volumn 6, Issue 3, 1998, Pages 287-290

  Climent, Miguel A ^a   Palau, Javier ^a   Ruiz, Amparo ^a   Soriano, Virtudes ^a   Aznar, Eduardo ^a   Olmos, Teresa ^a   Guillem, Vicente ^a  

^a INSTITUTO VALENCIANO DE ONCOLOGÍA   (Spain)

Author keywords

Antiemetic prophylaxis; Emesis; Granisetron; High dose chemotherapy

Indexed keywords

ANTINEOPLASTIC AGENT; CARBOPLATIN; CYCLOPHOSPHAMIDE; DEXAMETHASONE; GRANISETRON; HALOPERIDOL; LORAZEPAM; THIOTEPA;

ANTIEMETIC ACTIVITY; ANTINEOPLASTIC ACTIVITY; ARTICLE; BREAST CANCER; CANCER COMBINATION CHEMOTHERAPY; CLINICAL ARTICLE; DRUG EFFICACY; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; VOMITING;

ADULT; ANTIEMETICS; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BREAST NEOPLASMS; DEXAMETHASONE; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; DRUG THERAPY, COMBINATION; FEMALE; GRANISETRON; HALOPERIDOL; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; LORAZEPAM; MIDDLE AGED; NAUSEA; PALLIATIVE CARE; TREATMENT OUTCOME; VOMITING;

EID: 0031949678     PISSN: 09414355     EISSN: None     Source Type: Journal    
DOI: 10.1007/s005200050168     Document Type: Article

References (15)

1. Barbounis V, Koumakis G, Vassilomanolakis M, et al (1995) A phase II study of ondansetron as antiemetic prophylaxis in patients receiving high-dose polychemotherapy and stem cell transplantation. Support Care Cancer 3:301-306
2. Bregni M, Siena S, DiNicola M, et al (1991) Tropisetron plus haloperidol to amiliorate nausea and vomiting associated with high-dose alkylating agent cancer chemotherapy. Eur J Cancer 5 [27]:561-565
3. Cubeddu LX, Hoffmann IS, Fuenmayor NT, Finn AL (1990) Efficacy of ondansetron (GR38032F) and the role of serotonin in cisplatin-induced nausea and vomiting. N Engl J Med 322:810-816
4. Frakes L, Kosty M, Miller W, et al (1996) Early results of a pilot study of an all-oral antiemetic regimen for patients undergoing high-dose chemotherapy with peripheral blood progenitor cell trasplant. Ann Oncol 7 [Suppl 5]:673P, 139
5. Hawthorn J, Cunningham D (1990) Dexamethasone can potentiate the anti-emetic action of a 5HT3 receptor antagonist on cyclophosphamide-induced vomitigs in the ferret. Br J Cancer 61:56-60
6. Herrstedt J, Sigsgaard T, Boesgaard M, et al (1993) Granisetron plus metopimazine compared with ondansetron alone in patients receiving moderately emetogenic chemotherapy. N Engl J Med 328:1076-1080
7. Hulstaert F, Van Belle S, Bleiberg H, et al (1994) Optimal combination therapy with tropisetron in 445 patients with incomplete control of chemotherapy-induced nausea and vomiting. J Clin Oncol 12:2439-2446
8. 3 receptor antagonists in the prophylaxis of acute vomiting induced by moderately emetogenic chemotherapy - A randomised study. Eur J Cancer [A] 29:1669-1672
9. 3 antagonist, versus a standard anti-emetic regimen of chlorpromazine plus dexamethasone in the treatment of cytostatic-induced emesis. Eur J Cancer 26 [Suppl 1]:28-32
10. Morrow GR, Hickok JT, Rosenthal SN (1995) Progress in reducing nausea and emesis. Comparisons of ondansetron (zofran), granisetron (Kytril), and tropisetron (Navoban). Cancer 76:343-357
11. Mughal TI (1994) Efficacy of ondansetron and loracepam in controlling emesis associated with cytotoxic chemotherapy Acta Oncol 33:537-539
12. Or R, Drakos P, Nagler A, et al (1994) The anti-emetic efficacy and tolerability of tropisetron in patients conditioned with high-dose chemotherapy (with and without total body irradiation) prior to bone marrow transplantation. Support Care Cancer 2: 245-248
13. Schmidt M, Sorbe B, Högberg T, et al (1993) Efficacy and tolerability of tropisetron and dexamethasone in the control of nausea and vomiting induced by cisplatin. Ann Oncol 4 [Suppl 3]: S31-S34
14. 3 receptor antagonist, with metoclopromide-containing antiemetic cocktail in the prevention of cisplatin-induced emesis. Cancer 73:445-454
15. Tsavaris N, Charalambidis G, Pagou M, et al (1994) Comparison of ondansetron (GR 38032F) versus ondansetron alprazolam as antiemetic prophylaxis during cisplatin-containing chemotherapy Am J Clin Oncol 17:516-521